Tongyu Zhu

InstitutionFudan University
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 2 publications in June 2020 and July 2020 and Spetember 2020 and December 2020 and February 2021
    All Publications
    Bar chart showing 117 publications over 18 distinct years, with a maximum of 15 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wu N, Dai J, Guo M, Li J, Zhou X, Li F, Gao Y, Qu H, Lu H, Jin J, Li T, Shi L, Wu Q, Tan R, Zhu M, Yang L, Ling Y, Xing S, Zhang J, Yao B, Le S, Gu J, Qin J, Li J, Cheng M, Tan D, Li L, Zhang Y, Zhu Z, Cai J, Song Z, Guo X, Chen LK, Zhu T. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg Microbes Infect. 2021 Dec; 10(1):612-618. PMID: 33703996.
      Citations: 9     Fields:    Translation:HumansCells
    2. Li S, Wu B, Ling Y, Guo M, Qin B, Ren X, Wang C, Yang H, Chen L, Liao Y, Liu Y, Peng X, Xu C, Wang Z, Shen Y, Chen J, Liu L, Niu B, Zhu M, Liu L, Li F, Zhu T, Zhu Z, Zhou X, Lu H. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients. Front Immunol. 2021; 12:625881. PMID: 33717140.
      Citations: 2     Fields:    Translation:HumansCells
    3. Li A, Ling Y, Song Z, Cheng X, Ding L, Jiang R, Fu W, Liu Y, Hu H, Yuan S, Chen J, Zhu C, Fan J, Wang J, Jin Y, Zhang M, Zhu L, Sun P, Zhang L, Qin R, Zhang W, Qiu C, Shen Y, Zhang L, Shi Z, Zhao C, Zhu T, Lu H, Zhang X, Xu J. Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 02 24; 223(4):568-580. PMID: 33197260.
      Citations: 4     Fields:    Translation:HumansAnimals
    4. Chen YM, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, Sun L, Song ZG, Chen Z, Feng J, An Y, Yang J, Su Z, Sun S, Dai F, Chen Q, Lu Q, Li P, Ling Y, Yang Z, Tang H, Shi L, Jin L, Holmes EC, Ding C, Zhu TY, Zhang YZ. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J. 2020 12 15; 39(24):e105896. PMID: 33140861.
      Citations: 16     Fields:    Translation:Humans
    5. Shen Y, Zheng F, Sun D, Ling Y, Chen J, Li F, Li T, Qian Z, Zhang Y, Xu Q, Liu L, Huang Q, Shan F, Xu L, Wu J, Zhu Z, Song Z, Li S, Shi Y, Zhang J, Wu X, Mendelsohn JB, Zhu T, Lu H. Epidemiology and clinical course of COVID-19 in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1537-1545. PMID: 32573353.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    6. Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, Chen J, Wu Y, Xia S, Ling Y, Zhang Y, Xun J, Zhang R, Xie Y, Jiang S, Zhu T, Lu H, Wen Y, Huang J. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020 10 01; 180(10):1356-1362. PMID: 32808970.
      Citations: 85     Fields:    Translation:HumansCellsPHPublic Health
    7. Song ZG, Chen YM, Wu F, Xu L, Wang BF, Shi L, Chen X, Dai FH, She JL, Chen JM, Holmes EC, Zhu TY, Zhang YZ. Identifying the Risk of SARS-CoV-2 Infection and Environmental Monitoring in Airborne Infectious Isolation Rooms (AIIRs). Virol Sin. 2020 Dec; 35(6):785-792. PMID: 32986229.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    8. Fu W, Liu Y, Liu L, Hu H, Cheng X, Liu P, Song Z, Zha L, Bai S, Xu T, Yuan S, Lu F, Shang Z, Zhao Y, Wang J, Zhao J, Ding L, Chen J, Zhang L, Zhu T, Zhang X, Lu H, Xu J. An open-label, randomized trial of the combination of IFN-? plus TFF2 with standard care in the treatment of patients with moderate COVID-19. EClinicalMedicine. 2020 Oct; 27:100547. PMID: 32984784.
      Citations: 9     
    9. Fu W, Liu Y, Xia L, Li M, Song Z, Hu H, Yang Z, Wang L, Cheng X, Wang M, Jiang R, Liu L, Mao X, Chen J, Ling Y, Zhang L, Yan J, Shan F, Steinhart C, Zhang X, Zhu T, Xu J, Lu H. A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-? plus TFF2 in patients with moderate COVID-19. EClinicalMedicine. 2020 Aug; 25:100478. PMID: 32838238.
      Citations: 7     
    10. Li J, Guo M, Tian X, Wang X, Yang X, Wu P, Liu C, Xiao Z, Qu Y, Yin Y, Wang C, Zhang Y, Zhu Z, Liu Z, Peng C, Zhu T, Liang Q. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. Med (N Y). 2021 Jan 15; 2(1):99-112.e7. PMID: 32838362.
      Citations: 103     
    11. Meng X, Ling Y, Zhang L, Zhang Q, Dong P, Zhu T, Lu H. Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19. Biosci Trends. 2020 Jul 17; 14(3):161-167. PMID: 32536632.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    12. Chen J, Lu H, Melino G, Boccia S, Piacentini M, Ricciardi W, Wang Y, Shi Y, Zhu T. COVID-19 infection: the China and Italy perspectives. Cell Death Dis. 2020 06 08; 11(6):438. PMID: 32513951.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    13. Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, Fang C, Shan F, Mei X, Shi J, Song F, Yang Z, Ding Z, Su X, Lu H, Zhu T, Zhang Z, Shi L, Shi Y. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020; 10(12):5613-5622. PMID: 32373235.
      Citations: 76     Fields:    Translation:HumansCellsPHPublic Health
    14. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 05; 80(5):e1-e6. PMID: 32171869.
      Citations: 288     Fields:    Translation:HumansCellsPHPublic Health
    Zhu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (261)
    Explore
    _
    Co-Authors (233)
    Explore
    _
    Similar People (60)
    Explore
    _